In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler

Abstract

The tested composite seems to be a promising option for local therapy of surgically treated bone infections. The main advantages are the antibiotic release for a definite time period with therapeutic concentrations, which may minimize slow residual release at suboptimal concentrations.